CU6 clarity pharmaceuticals ltd

CU6 - ASX Charts, page-1860

  1. 5,087 Posts.
    lightbulb Created with Sketch. 2047
    Whilst its splitting hairs i thought it important to establish the correctness of the Financial Report and so i contacted the Company, and had it confirmed:
    1. At 31 Dec 2024 Clarity held $111.2 million in liquid assets, plus an additional $11 million R&D estimated receivable. Thus the combined Funding at that date was $122 million.
    2. The "apparent discrepancy" Hingdog referred to related to the date of signing of the Directors Report, 28 Feb 2025.

    An extra $11 million is not insignificant IMO.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$2.52
Change
0.130(5.44%)
Mkt cap ! $810.1M
Open High Low Value Volume
$2.39 $2.54 $2.37 $5.141M 2.072M

Buyers (Bids)

No. Vol. Price($)
2 6820 $2.50
 

Sellers (Offers)

Price($) Vol. No.
$2.52 3500 1
View Market Depth
Last trade - 16.17pm 27/06/2025 (20 minute delay) ?
CU6 (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.